Zobrazeno 1 - 10
of 576
pro vyhledávání: '"Marc P, Bonaca"'
Autor:
Marc Cohen, MD, Alex C. Spyropoulos, MD, Shaun G. Goodman, MD, Sarah A. Spinler, PharmD, Marc P. Bonaca, MD, Theresa M. Redling, DO, Gautam Visveswaran, MD, Sumit Sohal, MD, MS
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 8, Iss 4, Pp 321-328 (2024)
Externí odkaz:
https://doaj.org/article/40b70e343e16486a952fdb481ac67d30
Publikováno v:
Journal of the Society for Cardiovascular Angiography & Interventions, Vol 3, Iss 10, Pp 102286- (2024)
Externí odkaz:
https://doaj.org/article/30adc76580f040878e556f0bccc0ce67
Autor:
Zhong Yuan, Bennett Levitan, Hsiaowei Deng, Michael Szarek, Rupert M. Bauersachs, Scott D. Berkowitz, Lloyd Haskell, Elliot S. Barnathan, Marc P. Bonaca
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 8 (2024)
Background The VOYAGER PAD (Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities
Externí odkaz:
https://doaj.org/article/cb7732979fc142828382971a3178e404
Autor:
Amelia Iglesias, Ashley Ambrose, Stephanie Coronel-Mockler, Kristin Kilbourn, Marc P. Bonaca, Raymond O. Estacio, Mori J. Krantz
Publikováno v:
BMC Public Health, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Community Heart Health Actions for Latinos at Risk (CHARLAR) is a promotora-led cardiovascular disease (CVD) risk-reduction program for socio-demographically disadvantaged Latinos and consists of 11 skill-building sessions. The CO
Externí odkaz:
https://doaj.org/article/9607bb16616b4863843eda8e4084c53e
Autor:
Henry S. Cheng, Daniel Pérez-Cremades, Rulin Zhuang, Anurag Jamaiyar, Winona Wu, Jingshu Chen, Aspasia Tzani, Lauren Stone, Jorge Plutzky, Terence E. Ryan, Philip P. Goodney, Mark A. Creager, Marc S. Sabatine, Marc P. Bonaca, Mark W. Feinberg
Publikováno v:
JCI Insight, Vol 8, Iss 10 (2023)
Patients with peripheral artery disease (PAD) and diabetes compose a high-risk population for development of critical limb ischemia (CLI) and amputation, although the underlying mechanisms remain poorly understood. Comparison of dysregulated microRNA
Externí odkaz:
https://doaj.org/article/3e5659fa89f24a509170d7bf63c2bd7c
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Diagnostic testing accessibility and asymptomatic transmission of SARS-CoV-2 present major challenges for curbing and preventing community prevalence of COVID-19. At-home sample collection for molecular testing provides a convenie
Externí odkaz:
https://doaj.org/article/bdb19e4994e04d6c92466052986eea7d
A miRNA/CXCR4 signaling axis impairs monopoiesis and angiogenesis in diabetic critical limb ischemia
Autor:
Henry S. Cheng, Rulin Zhuang, Daniel Pérez-Cremades, Jingshu Chen, Anurag Jamaiyar, Winona Wu, Grasiele Sausen, Aspasia Tzani, Jorge Plutzky, Jorge Henao-Mejia, Philip P. Goodney, Mark A. Creager, Marc S. Sabatine, Marc P. Bonaca, Mark W. Feinberg
Publikováno v:
JCI Insight, Vol 8, Iss 7 (2023)
Patients with peripheral artery disease (PAD) and diabetes have the highest risk of critical limb ischemia (CLI) and amputation, yet the underlying mechanisms remain incompletely understood. MicroRNA (miRNA) sequencing of plasma from diabetic patient
Externí odkaz:
https://doaj.org/article/f2fe1fa1dd814c8fbc8a3dcf4c6f5b75
Autor:
Connie N. Hess, Iris Baumgartner, Sonia S. Anand, Mark R. Nehler, Manesh R. Patel, E. Sebastian Debus, Michael Szarek, Warren Capell, Eva Muehlhofer, Scott D. Berkowitz, Lloyd P. Haskell, Rupert M. Bauersachs, Marc P. Bonaca, Judith Hsia
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 12 (2022)
Background Despite high female prevalence of peripheral artery disease (PAD), little is known about sex‐based outcomes after lower extremity revascularization (LER) for symptomatic PAD. The effects of rivaroxaban according to sex following LER have
Externí odkaz:
https://doaj.org/article/e206edcaf2794bc898a22f84d5fb18a2
Autor:
Michael Szarek, Connie Hess, Manesh R. Patel, W. Schuyler Jones, Jeffrey S. Berger, Iris Baumgartner, Brian Katona, Kenneth W. Mahaffey, Lars Norgren, Juuso Blomster, Frank W. Rockhold, Judith Hsia, F. Gerry R. Fowkes, Marc P. Bonaca
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 11 (2022)
Background Peripheral artery disease (PAD) is associated with heightened risk for major adverse cardiovascular and limb events, but data on the burden of risk for total (first and potentially subsequent) events, and the association with polyvascular
Externí odkaz:
https://doaj.org/article/18699052c2634fccb3f16e04b1efee27
Autor:
Mario Enrico Canonico, Raffaele Piccolo, Marisa Avvedimento, Attilio Leone, Salvatore Esposito, Anna Franzone, Giuseppe Giugliano, Giuseppe Gargiulo, Connie N. Hess, Scott D. Berkowitz, Judith Hsia, Plinio Cirillo, Giovanni Esposito, Marc P. Bonaca
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 10, Iss 4, p 164 (2023)
Patients with peripheral artery disease (PAD) are at an increased risk of major adverse cardiovascular events, and those with disease in the lower extremities are at risk of major adverse limb events primarily driven by atherothrombosis. Traditionall
Externí odkaz:
https://doaj.org/article/7f11cb4f21d846c59ef41f11ab56eddb